Apimeds Pharmaceuticals US, Inc. (APUS) stock
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.23−0.04 (-1.76%)
Close on Nov 13, 2026Market cap $3.37MP/E –Yield –
Apimeds Pharmaceuticals US total assets
Total assets on the balance sheet at the end of each period.
Apimeds Pharmaceuticals US's total assets was $127.62M at Jun 30, 2026. For fiscal 2025 it was $164.18M, up 1257338.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $164.18M | +1257338.4% |
| FY2024 | Dec 31, 2024 | $13.06K | -96.9% |
| FY2023 | Dec 31, 2023 | $422.08K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $127.62M | +1110.1% |
| Q1 FY2026 | Mar 31, 2026 | $141.22M | +54235.1% |
| Q4 FY2025 | Dec 31, 2025 | $164.18M | +1257338.4% |
| Q3 FY2025 | Sep 30, 2025 | $9.25M | +2091.6% |
| Q2 FY2025 | Jun 30, 2025 | $10.55M | – |
| Q1 FY2025 | Mar 31, 2025 | $259.90K | – |
| Q4 FY2024 | Dec 31, 2024 | $13.06K | – |
| Q4 FY2023 | Dec 31, 2023 | $422.08K | – |
See a number that looks wrong?